Showing results (481-490 of 518) with videos related to

Sort By:
Pageof 52
Medrxiv : the Preprint Server for Health Sciences|September 4, 2024
Advancing long-read nanopore genome assembly and accurate variant calling for rare disease detectionShloka Negi, Sarah L Stenton, Seth I Berger, et al.
JCO Clinical Cancer Informatics|March 20, 2020
Cancer Imaging Phenomics via CaPTk: Multi-Institutional Prediction of Progression-Free Survival and Pattern of Recurrence in GlioblastomaAnahita Fathi Kazerooni, Hamed Akbari, Gaurav Shukla, et al.
American Journal of Human Genetics|January 25, 2025
Advancing long-read nanopore genome assembly and accurate variant calling for rare disease detectionShloka Negi, Sarah L Stenton, Seth I Berger, et al.
Biorxiv : the Preprint Server for Biology|January 13, 2025
Hydralazine inhibits cysteamine dioxygenase to treat preeclampsia and senesce glioblastomaKyosuke Shishikura, Jiasong Li, Yiming Chen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 22, 2022
Distinguishing Progression from Pseudoprogression in Glioblastoma Using 18F-Fluciclovine PETAli Nabavizadeh, Stephen J Bagley, Robert K Doot, et al.
Plos One|March 11, 2011
A survey of new temperature-sensitive, embryonic-lethal mutations in C. elegans: 24 alleles of thirteen genesSean M O'Rourke, Clayton Carter, Luke Carter, et al.
Science Advances|October 15, 2025
Hydralazine inhibits cysteamine dioxygenase to treat preeclampsia and senesce glioblastomaKyosuke Shishikura, Jiasong Li, Yiming Chen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 19, 2026
Metabolic Imaging and Molecular Signatures Reveal Metabolic Phenotypes in Recurrent GlioblastomaElizabeth J Li, Adam Kraya, Pedro Costa-Pinheiro, et al.
International Journal of Cancer|April 24, 2026
Generation of Allogeneic CAR-T Circumvents Functional Deficits in Patient-Derived Autologous Product for GlioblastomaSabra K Salim, Muhammad Vaseem Shaikh, Jeffrey Wei, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2019
Clinical Utility of Plasma Cell-Free DNA in Adult Patients with Newly Diagnosed Glioblastoma: A Pilot Prospective StudyStephen J Bagley, S Ali Nabavizadeh, Jazmine J Mays, et al.
Pageof 52